maps glp 1 program GLP-1 Drugs, Digital Health & Obesity Trends in 2026 Technologies enabling long-term health outcomes

doi:10.7759/cureus.34723 OBrien PE, Hindle A, Brennan L, et al

doi: 10.1038/s41467-018-08051-7 36 GaneshB

Loss of appetite is not common

An alternative mechanism (not mutually exclusive with reward modulation) is suggested by a study on nicotine, namely, that GLP1 receptor stimulation may promote satiety and avoidance of aversive effects of the drug, in this case nicotine, via a habenuladependent mechanism (Tuesta et al., 2017)

Her academic background, coupled with extensive practical experience, has made her highly effective in the field of translational medicine, significantly advancing the translation of scientific findings in cardiovascular and metabolic diseases into clinical applications